Therefore, this study aimed to evaluate the expression levels of ACE2 and TMPRSS2 in nasopharyngeal samples before, during, and after SARS-CoV-2 infection, to understand the influence of these levels on the pathogenicity of COVID-19. The gene discussed is ACE2; the disease is COVID-19.